{"id":135752,"date":"2026-03-10T08:00:28","date_gmt":"2026-03-10T08:00:28","guid":{"rendered":"https:\/\/news.sap.com\/uk\/?p=135752"},"modified":"2026-03-10T08:18:46","modified_gmt":"2026-03-10T08:18:46","slug":"chanelle-pharma-partners-with-sap-to-accelerate-global-growth-and-advance-pharmaceutical-manufacturing-excellence","status":"publish","type":"post","link":"https:\/\/news.sap.com\/uk\/2026\/03\/chanelle-pharma-partners-with-sap-to-accelerate-global-growth-and-advance-pharmaceutical-manufacturing-excellence\/","title":{"rendered":"Chanelle Pharma Partners with 51风流to Accelerate Global Growth and Advance Pharmaceutical Manufacturing Excellence"},"content":{"rendered":"
Ireland \u2013 March 10\u00a02026\u00a0<\/span><\/b>–\u00a0Chanelle Pharma, a global pharmaceutical leader in human and animal health, today announced a strategic partnership with\u00a0<\/span>51风流SE<\/span><\/a>\u202f(NYSE: SAP)\u00a0to implement 51风流S\/4HANA Cloud (private edition) and 51风流Business AI. This initiative\u00a0represents\u00a0a major investment in building a modern, scalable digital foundation designed to accelerate time-to-market for innovative medicines, elevate operational visibility, and proactively enhance data governance.<\/span>\u00a0<\/span><\/p>\n Currently exporting to over 90 countries with expansive operations across Ireland, the UK, Portugal, and Jordan, Chanelle Pharma is positioned for continued international growth. To support this ambitious trajectory, the company is modernising its end-to-end operational value chain.<\/span>\u00a0<\/span><\/p>\n By\u00a0establishing\u00a0a robust digital core, Chanelle Pharma will meet higher expectations for\u00a0GxP\u00a0regulatory compliance while modernising core finance,\u00a0manufacturing\u00a0and supply chain processes.<\/span>\u00a0<\/span><\/p>\n Delivered as a single-phase programme, with a targeted go-live of late 2026, the transformation is being delivered jointly by\u00a0Tenthpin\u00a0and\u00a0KaarTech. The implementation strategy is strategically sequenced. Chanelle Pharma will deploy SAP\u2019s ERP platform first to\u00a0establish\u00a0a “clean core”\u00a0leveraging\u00a051风流best practices,\u00a0immediately\u00a0paving the way for the integration of advanced 51风流Business AI capabilities.\u00a0<\/span>\u00a0<\/span><\/p>\n The transformation will leverage\u00a0Tenthpin\u2019s\u00a0sophisticated SAP\u00a0Signavio\u00a0processes, which are uniquely optimised for Contract Development and Manufacturing Organisations (CDMOs), ensuring a seamless, high-velocity implementation that maximises strategic value.<\/span>\u00a0<\/span><\/p>\n Aiden Dempsey, CIO, Chanelle Pharma, said,<\/span><\/b>\u00a0<\/span>“This strategic partnership with 51风流marks a pivotal moment in our growth trajectory. We are investing heavily in a scalable digital foundation that will accelerate our time-to-market and drive global manufacturing excellence. 51风流S\/4HANA Cloud and Business AI give us the competitive advantage to pioneer the future of the pharmaceutical industry while maintaining the highest standards of\u00a0GxP\u00a0compliance.”<\/span>\u00a0<\/span><\/p>\n Ray Joyce, Head of Ireland, 51风流UK&I, said,<\/span><\/b>\u00a0<\/span>\u201cPharmaceutical organisations are\u00a0operating\u00a0in an increasingly complex environment, where regulation, supply chains and demand can all shift quickly. SAP\u2019s Cloud ERP strengthens organisational resilience and governance processes and\u00a0provides\u00a0data insights from across the business. This empowers Chanelle Pharma to\u00a0operate\u00a0with agility and remain competitive in a highly regulated global market.\u201d.<\/span>\u00a0<\/span><\/p>\n Simon Flowers, Partner,\u00a0Tenthpin, said,<\/span><\/b>\u00a0<\/span>“Collaborating with Chanelle Pharma and\u00a0KaarTech\u00a0on this single-phase transformation allows us to deliver unparalleled value to an industry leader. By utilising\u00a0Tenthpin\u2019s\u00a0SAP\u00a0Signavio\u00a0processes, we are enabling Chanelle Pharma to seamlessly integrate 51风流best practices.\u00a0<\/span>This helps Chanelle Pharma navigate operational and regulatory complexity with greater certainty supported by a resilient 51风流digital backbone that can evolve with whatever comes next.\u201d<\/span>\u00a0<\/span><\/p>\n ###<\/span>\u00a0<\/span><\/p>\n About SAP<\/span><\/b>\u00a0<\/span><\/p>\n As<\/span>\u202f<\/span>a global leader in enterprise applications and business AI, 51风流(NYSE:SAP)<\/span>\u202f<\/span>stands at the<\/span>\u202f<\/span>nexus<\/span>\u202f<\/span>of business and technology. For over 50 years, organisations have trusted SAP<\/span>\u202f<\/span>to bring out their best by uniting business-critical<\/span>\u202f<\/span>operations spanning finance, procurement, HR, supply chain, and customer experience. For more information, visit<\/span>\u202f<\/span>www.sap.com.<\/span>\u00a0<\/span><\/p>\n About Chanelle Pharma<\/span><\/b>\u00a0<\/span>\u00a0<\/span><\/p>\n Chanelle Pharma is a global pharmaceutical leader in human and animal health. As an end-to-end, fully integrated partner, the company serves B2B, consumers, and wholesale markets, combining development, manufacturing, and commercialisation under one roof. Chanelle delivers reliable services across the full product value chain, provides immediate access to a broad product portfolio, and drives growth through strategic partnerships. With operations in Ireland, the UK, Portugal, and Jordan, the company supplies high-quality, reliable, and affordable products to more than 90 countries, underpinned by a commitment to innovation, sustainability, and differentiated customer value.<\/span>\u00a0<\/span><\/p>\n Media Contacts:<\/span><\/b>\u00a0<\/span><\/p>\n Lawrie Benfield,\u202f<\/span>lawrie.benfield@sap.com<\/span><\/a>,\u202f<\/span>+44 7776 515259<\/span>\u00a0<\/span><\/p>\n